Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Class A common stock, par value $0.00001 per share
-
Shares outstanding
-
114M
-
Number of holders
-
4
-
Total 13F shares, excl. options
-
117K
-
Shares change
-
-14.7K
-
Total reported value, excl. options
-
$6.53M
-
Value change
-
-$825K
-
Number of buys
-
2
-
Number of sells
-
-2
-
Price
-
$55.96
Significant Holders of 10x Genomics, Inc. - Class A common stock, par value $0.00001 per share (TXG) as of Q4 2023
4 filings reported holding TXG - 10x Genomics, Inc. - Class A common stock, par value $0.00001 per share as of Q4 2023.
10x Genomics, Inc. - Class A common stock, par value $0.00001 per share (TXG) has 4 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 117K shares
of 114M outstanding shares and own 0.1% of the company stock.
Largest 10 shareholders include FMR LLC (12.8M shares), VANGUARD GROUP INC (9.01M shares), BAILLIE GIFFORD & CO (7.92M shares), BlackRock Inc. (5.71M shares), MORGAN STANLEY (4.18M shares), ARK Investment Management LLC (4.04M shares), SANDS CAPITAL MANAGEMENT, LLC (3.59M shares), BROWN CAPITAL MANAGEMENT LLC (3.53M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.1M shares), and Invesco Ltd. (2.33M shares).
This table shows the top 4 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.